How to Take Creon (Pancrelipase)
Creon must be taken during the meal—not before or after—to maximize mixing with food and ensure proper digestion of nutrients. 1
Timing and Administration
Take Creon during meals, not before or after. The fundamental principle is that pancreatic enzyme replacement therapy (PERT) "treats the meal, not the pancreas," so timing is critical for optimal enzyme-food mixing 1. This approach maximizes the therapeutic benefit by ensuring enzymes are present when food enters the duodenum.
For Intact Capsules:
- Swallow capsules whole during the meal
- Never crush, chew, or retain capsules in your mouth—this disrupts the protective enteric coating, causing early enzyme release, oral mucosa irritation, and loss of enzyme activity 2
- Take with adequate water or juice
For Those Unable to Swallow Capsules:
- Carefully open the capsule
- Sprinkle contents on a small amount of acidic soft food with pH ≤4.5 (such as applesauce) at room temperature
- Do not mix with foods having pH >4.5—this will destroy the enteric coating 2
- Swallow the mixture immediately without chewing
- Follow with water or juice to ensure complete ingestion 2
Critical pitfall: Never mix Creon directly into formula or breast milk before administration, particularly for infants 2
Dosing Guidelines
Adults:
Start with at least 40,000 USP units of lipase with each main meal and half that dose (20,000 units) with snacks 1. The 2023 AGA guidelines are explicit about this starting point, which can be adjusted based on meal size and fat content.
The typical dosing range is:
- Main meals: 40,000-50,000 lipase units (can increase up to 2-3 times this amount if needed) 3, 4
- Snacks: 20,000-25,000 lipase units 5, 4
Dose Adjustments:
Subsequent dosing should be proportional to:
- Meal size
- Fat content of the meal 1
- Clinical response (reduction in steatorrhea, weight gain, symptom improvement) 1
Maximum safe dosing: Generally should not exceed 2,500 lipase units/kg body weight per meal or 10,000 lipase units/kg body weight per day 2. Doses exceeding 6,000 lipase units/kg per meal have been associated with fibrosing colonopathy, particularly in children <12 years 2.
Important Considerations
Acid Suppression:
- Enteric-coated formulations (like Creon) do not require acid suppression 1
- However, adding a proton pump inhibitor or H2-blocker may improve efficacy in some patients 1
- Non-enteric-coated preparations (Viokace) require co-treatment with acid-reducing agents 1
Dietary Modifications:
Combine PERT with:
- Low-moderate fat diet with frequent smaller meals
- Avoid very-low-fat diets (counterproductive) 1
- Fat-soluble vitamin supplementation 1
Monitoring Response:
Success is measured by 1:
- Reduction in steatorrhea and GI symptoms
- Weight gain and improved muscle mass
- Improved fat-soluble vitamin levels
- Better quality of life
If inadequate response: Double the dose before considering alternative therapies or investigating other causes of malabsorption (celiac disease, small intestinal bacterial overgrowth, bile acid malabsorption) 5, 4.
The evidence strongly supports that proper timing (during meals) and adequate dosing (starting at 40,000 units lipase per meal) are the two most critical factors for successful PERT outcomes, directly impacting morbidity through prevention of malnutrition, weight loss, and vitamin deficiencies that lead to osteoporosis and reduced survival 1.